Skip to main content
MS-DRG 843 · MDC 17 · Medical

MS-DRG 843: Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 843

FY2027 relative weight
1.9453
Higher than 61% of all MS-DRGs
Change vs FY2026
-2.5%
FY2026 weight 1.9948
Geometric mean LOS
5.3 days
Arithmetic mean 7.3 days
MDC
17
Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms
Severity level
with MCC (major complication or comorbidity)
National unadjusted operating payment
$13,321.41
Weight × $6,848.00 FY2027 standardized amount; capital adds $1,050.36
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 843 is a medical group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms), at the highest of three severity levels in its CC/MCC family. CMS assigns it a FY2027 relative weight of 1.9453 with a geometric mean length of stay of 5.3 days and an arithmetic mean of 7.3. Its weight moved down 2.5% from FY2026 (1.9948). That weight is higher than 61% of all MS-DRGs. Its weight sits 55.0% above DRG 844 (with CC, 1.2551) and 130.3% above DRG 845 (without CC/MCC, 0.8447). The v44 Definitions Manual assigns it through 110 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 843 the FY2027 relative weight is 1.9453 against 1.9948 in FY2026, a fall of 2.48%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 843
MetricFY2026FY2027Change
Relative weight1.99481.9453-0.0495
Geometric mean LOS (days)5.45.3-0.1
Arithmetic mean LOS (days)7.57.3-0.2
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 843 shares its base definition with 2 other MS-DRGs split by severity. The family's weights span 0.8447 to 1.9453, a 2.30× spread, which is the payment effect of documenting qualifying complications and comorbidities.

MS-DRGs in the same base group as DRG 843
DRGTitleFY2027 weightGMLOSNational operating payment
843Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC1.94535.3$13,321.41
844Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with CC1.25513.7$8,594.92
845Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses without CC/MCC0.84472.3$5,784.51

At the national rate, documenting the family's top severity level (DRG 843, $13,321.41) instead of its base level (DRG 845, $5,784.51) changes the operating payment by $7,536.91, the amount at stake when a reviewer removes the MCC or CC that put the stay here. The figures are national operating amounts before the hospital-specific adjustments described below.

National unadjusted payment for DRG 843

Multiplying the FY2027 relative weight (1.9453) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. Across the CC/MCC family the operating amount spans $7,536.91.

FY2027 national unadjusted IPPS payment for MS-DRG 843
ComponentNational rateDRG 843
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$13,321.41
Capital (federal rate)$539.95$1,050.36
Operating plus capital$14,371.77
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $12,904.71 to $13,217.24 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 843.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 110 ICD-10-CM codes in the logic for DRG 843; 34 of them also map to a CMS-HCC V28 payment category, across 7 categories. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 843
V28 HCCCategoryShared codesExamples
HCC 23Prostate, Breast, and Other Cancers and Tumors14C76.40, C76.41, C76.42
HCC 21Lymphoma and Other Cancers7C37, C7A.00, C7A.091
HCC 17Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4C7B.00, C7B.09, C7B.1
HCC 18Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid3C79.89, C79.9, C80.0
HCC 22Bladder, Colorectal, and Other Cancers3D3A.00, D3A.098, D3A.8
HCC 19Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers2C45.7, C45.9
HCC 20Lung and Other Severe Cancers1C48.0

New for FY2027: codes that group to DRG 843

IPPS Tables 6A and 6B assign 1 new ICD-10-CM code to DRG 843 from October 1, 2026. Encoders and edit tables that still run the v43 code set reject these codes or group them elsewhere, so check them first when a FY2027 discharge in this DRG fails an edit. The FY2027 ICD-10 code-change report lists every addition and deletion with its CC level and MS-DRGs.

New FY2027 ICD-10-CM codes that group to DRG 843
ICD-10-CMDescriptionSeverity
C79.83Secondary malignant neoplasm of oral cavityCC

Grouper logic (v44 Definitions Manual)

The manual's split table for Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses gives one row per combination of criteria and the MS-DRG it assigns. DRG 843 is the row where MCC is Yes.

Split table for Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses
MCCCCDRG
Yesnot checked843
NoYes844
NoNo845

Principal Diagnosis: 110 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Principal Diagnosis codes in the logic for DRG 843 (sample)
ICD-10-CM codeDescription
C37Malignant neoplasm of thymus
C45.7Mesothelioma of other sites
C45.9Mesothelioma, unspecified
C48.0Malignant neoplasm of retroperitoneum
C76.40Malignant neoplasm of unspecified upper limb
C76.41Malignant neoplasm of right upper limb
C76.42Malignant neoplasm of left upper limb
C76.50Malignant neoplasm of unspecified lower limb
C76.51Malignant neoplasm of right lower limb
C76.52Malignant neoplasm of left lower limb
C76.8Malignant neoplasm of other specified ill-defined sites
C79.83Secondary malignant neoplasm of oral cavity

Code editor, HAC and CC/MCC exclusion notes for DRG 843

Because this family splits by CC and MCC, a secondary diagnosis on the hospital-acquired condition list that is reported with a present-on-admission indicator of N or U does not count toward the severity level, and a CC or MCC excluded by the principal diagnosis does not count either. Check a secondary diagnosis and its CC exclusion before relying on it for the higher member.

The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 843; these are the ones that are also on a Medicare Code Editor list and can draw that edit.

Medicare Code Editor v44 lists that include codes in the logic of DRG 843
MCE editListCodesExamples
Edit 9unacceptable principal diagnosis62C80.2, Z85.00, Z85.01

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family splits by severity, auditors target CC and MCC capture: each secondary diagnosis must be documented as present, monitored, evaluated or treated during the stay to survive a DRG-validation review. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 843

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 843

What is MS-DRG 843?

MS-DRG 843 is "Other Myeloproliferative Disorders or Poorly Differentiated Neoplastic Diagnoses with MCC", a medical Medicare Severity Diagnosis-Related Group in MDC 17 (Myeloproliferative Diseases and Disorders, Poorly Differentiated Neoplasms). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 843?

The FY2027 relative weight is 1.9453 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 1.9948, a change of -2.5%.

What is the Medicare base payment for MS-DRG 843?

$13,321.41 for operating costs plus $1,050.36 for capital, $14,371.77 together, at the FY2027 national rates: weight 1.9453 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). DRG 844 (with CC) comes to $8,594.92 operating on the same basis. DRG 845 (without CC/MCC) comes to $5,784.51 operating on the same basis. The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 843?

CMS reports a geometric mean length of stay of 5.3 days and an arithmetic mean of 7.3 days for FY2027. The geometric mean is used for transfer-payment calculations.

Which DRGs are in the same CC/MCC family as 843?

DRG 844 (with CC, weight 1.2551, GMLOS 3.7 days); DRG 845 (without CC/MCC, weight 0.8447, GMLOS 2.3 days). Together with DRG 843 the family spans 0.8447 to 1.9453, a 2.30x spread, so documented complications and comorbidities change payment materially.

What documentation supports the severity level of DRG 843?

DRG 843 requires at least one secondary diagnosis on the CMS Major Complication or Comorbidity list, documented as present and clinically addressed during the stay (monitored, evaluated, treated or extending the stay). Conditions such as acute respiratory failure, severe sepsis or acute kidney injury with specified cause qualify only when the attending's note states the diagnosis itself, not just the lab values. Recovery auditors downgrade this group to the CC or base level when the MCC rests on an unconfirmed query or a resolved historical condition, so the query response and the discharge summary must agree.

Which codes group to DRG 843?

The v44 Definitions Manual lists 110 principal diagnosis codes for this group. Examples from the principal diagnosis list, C76.51 (Malignant neoplasm of right lower limb); C76.52 (Malignant neoplasm of left lower limb); C76.8 (Malignant neoplasm of other specified ill-defined sites); C79.83 (Secondary malignant neoplasm of oral cavity).

Is DRG 843 a post-acute transfer DRG?

No. DRG 843 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.